2022 Speakers

Browse our confirmed speakers below, or click here to take a look at the 2022 Agenda

Speakers

Alan Griffith

Vice President of Research • PureSpring Therapeutics
Speakers

Alex Hamilton

Partner • Syncona Ltd
Speakers

Alexander Natz

Secretary General • EUCOPE
Speakers

Alexandre Reeber

CEO • Core Biogenesis
Speakers

Allison Blair

Head of Laboratory • NHS Blood and Transplant
Speakers

Amandine Breton

Director of MSAT & Analytical Sciences  • Orchard Therapeutics
Speakers

Amir Hefni

Worldwide Commercial and Region Europe Head for Cell & Gene • Novartis
Speakers

Andrea Zobel

Senior Director, Personalized Supply Chain • World Courier Management Ltd
Speakers

Angela Justice

Chief People Officer • TCR2 Therapeutics
Speakers

Ann-Hunter Van Kirk

Senior Equity Research Analyst Biopharmaceuticals • Bloomberg Intelligence
Speakers

Anna Dickinson

Life Sciences – Policy Manager • Public Policy Projects
Speakers

Anthony Davies

Founder & CEO • Dark Horse Consulting
Speakers

Arthur Stril

Chief Business Officer • Cellectis
Speakers

Bastian Nießing

Group Manager, Automation in Life Sciences • Fraunhofer IPT
Speakers

Ben Mosley

Director of Skills Growth • Cell and Gene Therapy Catapult
Speakers

Bryan Kobel

CEO • TC Biopharm
Speakers

Bryan Poltilove

Operating Partner • BroadOak Partners
Speakers

Catriona Crombie

Associate Director of Technology Transfer • LifeArc
Speakers

Daniel Cermeno

Product Manager • Core Biogenesis
Speakers

Daniel Marroyen

Senior Life Science Industry Consultant, Europe • Emerson Automation Solutions
Speakers

David Allison

Chief Executive • TREAT-NMD
Speakers

David Horna

Co-Founder & Chief Operating Officer • Aglaris
Speakers

David Sourdive

Co-Founder & EVP CMC Manufacturing • Cellectis
Speakers

David Wolton

Engineering Technology Lead • Takeda
Speakers

Dmitrij Hristodorov

Partner • Forbion
Speakers

Dorothea Ledergerber

Chief Technical Officer • Tigen Pharma
Speakers

Edison Bicudo

Research Fellow • UCL
Speakers

Edward Samuel

EVP Technical Operations • Achilles Therapeutics
Speakers

Elsa Abranches

Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • AstraZeneca
Speakers

Emmanuelle Cameau

Strategic Technology Partnership Leader • Pall Corporation
Speakers

Francesca Gliubich

Director, London Advanced Therapies • King’s College London
Speakers

Francesca Kinsella

Consultant Haematologist (Stem Cell Transplantation) • University of Birmingham
Speakers

Francesca Pasinelli

Director General • Fondazione Telethon
Speakers

Frank Thielmann

Head Lean – Global Operational Excellence • Takeda
Speakers

Friedemann Übele

Head of Process Science • Tigen Pharma
Speakers

Giovanni Lorenzon

Bioprocess Specialist • Eppendorf
Speakers

Hanna Lesch

CTO • Exothera SA
Speakers

Hemant Dhamne

Head of Process Development – Gene Therapy Vector Facility • King’s College London
Speakers

Ian Rees

Inspectorate Strategy and Innovation • MHRA
Speakers

Jacqueline Barry

Chief Clinical Officer • Cell and Gene Therapy Catapult
Speakers

James Miskin

Chief Technical Officer • Oxford BioMedica (UK) Ltd
Speakers

Jason Jones

Chief Business Officer  • Ori Biotech
Speakers

Jenny Prange

CSO and Co-Founder • Muvon Therapeutics
Speakers

Joanna Norman

Senior Staff Scientist VGT • FUJIFILM Diosynth Biotechnologies
Speakers

Joel Eichmann

Co-Founder • Green Elephant Biotech
Speakers

John Campbell

Director, Tissues Cells & Advanced Therapeutics • Scottish National Blood Transfusion Service
Speakers

John Liddell

Chief Technologist • CPI
Speakers

John Spoors

Head of Commercial Medicines Policy Analysis • NHS England
Speakers

Jonathan Appleby

Chief Scientific Officer • Cell and Gene Therapy Catapult
Speakers

Judith Koliwer

Principal Consultant Cell and Gene Therapy • Körber
Speakers

Julia Sable

Director CMC Project Management • Tmunity Therapeutics
Speakers

Kai Pinkernell

Chief Medical Officer • GlycoStem
Speakers

Karin Blumer

Director Global Patient Engagement • Novartis
Speakers

Katherine Donigan

Senior Director of Science and Regulatory • BIO
Speakers

Kinnari Patel

Chief Operating Officer • Rocket Pharma
Speakers

Kwok Pang

Chief Operating Officer • Autolomous
Speakers

Laura Herbst

Research Fellow • Fraunhofer IPT
Speakers

Lee Aiyegbusi

Deputy Director Centre for Patient-Reported Outcomes Research (CPROR) • University of Birmingham CPROR
Speakers

Ludwig Camusot

Chief Corporate Development Officer • Cell Matters
Speakers

Marcos Langtry

Director of Commercial Development, Allogeneic Cell Therapy • Lonza Ltd
Speakers

Mark Kotter

Founder • Bit Bio
Speakers

Mark Lowdell

CSO/CMO • INmune Bio
Speakers

Mark Throsby

Chief Scientific Officer • Gadeta
Speakers

Mark Trusheim

Strategic Director, NEWDIGS and Visiting Scientist, • Massachusetts Institute of Technology (MIT)
Speakers

Martin Murphy

Chief Executive Officer • Syncona Investment
Speakers

Melanie Calvert

Professor of Outcomes Methodology • University of Birmingham CPROR
Speakers

Michael Delahaye

Director, Team Leader, Cell Therapy Bioprocessing • AstraZeneca
Speakers

Michael Leek

Executive Chairman & Founder • TC Biopharm
Speakers

Michael von Forstner

Global Head of Clinical Safety and Pharmacovigilance • Biogen
Speakers

Michela Gabaldo

Head Alliance Management & Regulatory Affairs • Fondazione Telethon
Speakers

Michelle Duquette

Director, Business Development – Cell Therapy • Invetech
Speakers

Miguel Forte

CEO • Bone Therapeutics
Speakers

Mimoun Azzouz

Director of GTIMC • University of Sheffield
Speakers

Mustafa Munye

Director R&D Operations • Complement Therapeutics
Speakers

Namir Hassan

CEO • Zelluna
Speakers

Natalie Ward

Associate Director, Regulatory Affairs, CMC • Adaptimmune
Speakers

Neil Dugdale

General Manager UK & Ireland • GenSight Biologics
Speakers

Nicholas Medcalf

Deputy Challenge Director for the Medicines Manufacturing Challenge • Innovate UK
Speakers

Nicola Redfern

Former Vice President Northern Europe • Bluebird Bio
Speakers

Niloofar Davoodi

Director Cell Therapy CMC • Takeda
Speakers

Ohad Karnieli

Founder & CEO • Adva Biotechnology
Speakers

Oliver Sexton

Investment Director • UK Innovation & Science Seed Fund
Speakers

Owen Smith

Partner • 4Bio
Speakers

Pamela Tranter

Head Translational Research Group, UCL Translational Research Office • UCL
Speakers

Pascal Joly

Principal • Catenion
Speakers

Qasim Rafiq

Associate Professor Cell & Gene Therapy • UCL
Speakers

Rachel Yao

Associate Director Technical Operations • SOTIO Biotech Inc
Speakers

Rodolphe Clerval

CEO • Coave Therapeutics
Speakers

Ryan Hicks

Senior Director – Head of Bioscience Cell Therapy, BioPharmaceuticals, R&D Cell Therpay • AstraZeneca
Speakers

Sanjin Zvonic

Vice President Business Development and Practice Expert • Dark Horse Consulting
Speakers

Shree Patel

EVP Patient Supply Operations • Achilles Therapeutics
Speakers

Silvio Weber

Director Industrial Workflow Development, Cellular Therapy • Miltenyi Biotec
Speakers

Simon Chandler

CEO • Rinri Therapeutics
Speakers

Simon Hort

Group Manager, Adaptive Production Control, Fraunhofer IPT  • Fraunhofer IPT
Speakers

Sofia Hakansson Buch

Vice President for Cell Therapy CMC • Novo Nordisk
Speakers

Stefanos Theoharis

Chief Business Officer • Bone Therapeutics
Speakers

Stephan Grupp

Medical Director Cell & Gene Therapy Lab • Children’s Hospital of Philadelphia
Speakers

Stephen Sullivan

Programme Manager & International Liason Officer • GAiT
Speakers

Steve Bloodworth

Head of Commercial Partnering & MarTech Deployment, • AstraZeneca
Speakers

Stuart Curbishley

Head of Business and Project Development – Advanced Therapies • University of Birmingham
Speakers

Sven Kili

Chief Executive Officer • Antion
Speakers

Takis Athanasopoulos

Director, Head of Patient Operations, Product Development & Supply Cell & Gene Therapy • GSK
Speakers

Tim Funnell

Partner • Monograph Capital
Speakers

Toby Proctor

Head of Manufacturing Science & Technology • Achilles Therapeutics
Speakers

Tom Whitehead

Co Founder & President • Emily Whitehead Foundation
Speakers

Troels Jordansen

CEO • GlycoStem
Speakers

Uta Griesenbach

Professor of Molecular Medicine, National Heart and Lung Institute • Imperial College London